scispace - formally typeset
Search or ask a question

Showing papers by "Piero Dalerba published in 2001"


Journal ArticleDOI
TL;DR: The data suggest that a subset of rhabdomyosarcoma patients could be eligible for active, specific immunotherapy directed against MAGE, BAGE and GAGE antigens.
Abstract: MAGE, BAGE and GAGE genes encode tumor-associated antigens that are presented by HLA class I molecules and recognized by CD8(+) cytolytic T lymphocytes. These antigens are currently regarded as promising targets for active, specific tumor immunotherapy because MAGE, BAGE and GAGE genes are expressed in many human cancers of different histotype and are silent in normal tissues, with the exception of spermatogonia and placental cells. MAGE, BAGE and GAGE gene expression has been extensively studied in different tumors of adults but is largely unknown in many forms of pediatric solid cancer. Using RT-PCR, we analyzed MAGE-1, MAGE-2, MAGE-3, MAGE-4, MAGE-6, BAGE, GAGE-1,-2 or -8 and GAGE-3,-4,-5,-6 or -7b gene expression in 31 samples of pediatric rhabdomyosarcoma, the most frequent form of malignant soft tissue tumor in children. MAGE genes were expressed in a substantial proportion of patients (MAGE-1, 38%; MAGE-2, 51%; MAGE-3, 35%; MAGE-4, 22%; MAGE-6, 35%), while expression of BAGE (6%); GAGE-1, GAGE-2 and GAGE-8 (9%); and GAGE-3, GAGE-4, GAGE-5, GAGE-6 and GAGE-7B (16%) was less frequent. Overall, 58% of tumors expressed at least 1 gene, and 35% expressed 3 or more genes simultaneously. Our data suggest that a subset of rhabdomyosarcoma patients could be eligible for active, specific immunotherapy directed against MAGE, BAGE and GAGE antigens.

48 citations


Book ChapterDOI
TL;DR: Melanoma is the tumor that was more frequently studied thanks to several clinical reports suggesting its antigenicity and to the availability of tumor cell lines and autologous T lymphocyte lines or clones that can be obtained from the majority of patients and used for in vitro studies.
Abstract: The molecular characterization of human tumor antigens has allowed a rapid translation of information gained in basic research into clinical protocols. Melanoma is the tumor that was more frequently studied thanks to several clinical reports suggesting its antigenicity and to the availability of tumor cell lines and autologous T lymphocyte lines or clones that can be obtained from the majority of patients and used forin vitrostudies’. However, several other tumor histotypes have been also analyzed though with less clear-cut results.

2 citations